Back
Bio-Techne Quote, Financials, Valuation and Earnings
Sponsored
TECH
Sponsored
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
40
TECH
Bio-Techne
Last Price:
64.10
Seasonality Move:
13.16%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.Bio-Techne Price Quote
$64.10
+1.44 (+2.3%)
(Updated: April 26, 2024 at 5:50 PM ET)
Bio-Techne Key Stats
Sell
40
Bio-Techne (TECH)
is a Sell
Day range:
$61.79 - $63.31
52-week range:
$51.79 - $89.91
Dividend yield:
0.51%
P/E ratio:
35.60
P/S ratio:
8.83
P/B ratio:
5.02%
Volume:
947.2K
Avg. volume:
1M
1-year change:
-20.41%
Market cap:
$9.8B
Revenue:
$1.1B
EPS:
$1.38
How Much Does Bio-Techne Make?
-
How Much Are Bio-Techne's Sales Annually?
TECH Revenues are $1.1B -
How Much Profit Does Bio-Techne's Make A Year?
TECH net income is $285.3M
Is Bio-Techne Growing As A Company?
-
What Is Bio-Techne's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0% -
What Is Bio-Techne's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.45%
Bio-Techne Stock Price Performance
-
Did Bio-Techne Stock Go Up Last Month?
Bio-Techne share price went down by -9.48% last month -
Did TECH's Share Price Rise Over The Last Year?
TECH share price fell by -20.41% over the past 1 year
What Is Bio-Techne 52-Week High & Low?
-
What Is Bio-Techne’s 52-Week High Share Price?
Bio-Techne has traded as high as $89.91 over the past 52 weeks -
What Is Bio-Techne’s 52-Week Low Share Price?
Bio-Techne has traded as low as $51.79 over the past 52 weeks
Bio-Techne Price To Free Cash Flow
-
Is Bio-Techne Stock Overvalued?
Bio-Techne is trading at a price to free cash flow ratio of 44.88 -
Is Bio-Techne Stock Undervalued?
Bio-Techne EV to Free Cash Flow ratio is 45.08 -
What Is Bio-Techne’s Price Earnings Growth Ratio?
TECH PEG ratio is 0.00 -
Is Bio-Techne Trading At A Premium To Earnings?
Bio-Techne EV to EBIT ratio is 38.24
Is It Risky To Buy Bio-Techne?
-
How Much Debt Does Bio-Techne Have?
Total long term debt quarterly is $447M -
How Much Cash Does Bio-Techne Have?
Cash and short term investments quarterly total is $135.7M -
What Is Bio-Techne’s Book Value Per Share?
Book value per share is 12.50
Is Bio-Techne Cash Flow Positive?
-
What Is TECH Cash Flow From Operations?
Cash flow from operations (TTM) is $276.4M -
What Is Bio-Techne’s Cash Flow From Financing?
Cash flow from financing (TTM) is $116.7M -
What Is Bio-Techne’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$423.6M
Bio-Techne Return On Invested Capital
-
Is Management Doing A Good Job?
TECH return on invested capital is 9.79% -
What Is Bio-Techne Return On Assets?
ROA measures how assets are converting to revenues and is 8.56% -
What Is TECH Return On Equity?
ROE is a measure of profitability and is 11.62%
Bio-Techne Earnings Date & Stock Price
-
What Is Bio-Techne's Stock Price Today?
A single share of TECH can be purchased today for 62.66 -
What Is Bio-Techne’s Stock Symbol?
Bio-Techne trades on the nasdaq under the ticker symbol: TECH -
When Is Bio-Techne’s Next Earnings Date?
The next quarterly earnings date for Bio-Techne is scheduled on May 1, 2024 -
When Is TECH's next ex-dividend date?
Bio-Techne's next ex-dividend date is February 9, 2024 -
How To Buy Bio-Techne Stock?
You can buy Bio-Techne shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bio-Techne Competitors
-
Who Are Bio-Techne's Competitors?
Below is a list of companies who compete with Bio-Techne or are related in some way:
Bio-Techne Dividend Yield
-
What Is TECH Dividend Yield?
Bio-Techne’s dividend yield currently is 0.51% -
What Is Bio-Techne’s Payout Ratio?
Bio-Techne’s payout ratio is 22.48% -
When Did Bio-Techne Last Pay A Dividend?
The latest dividend pay date is April 26, 2024 -
What Is Bio-Techne’s Dividend Per Share?
Bio-Techne pays a dividend of $0.08 per share
Bio-Techne Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -45.16% | -3.12% |
Revenue: | 0.38% | -1.85% |
Analyst Recommendations
Buy Recommendations: | 10 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 80.43 |
Upside from Last Price: | 28.36% |